Geron can proceed with early testing of an embryonic-stem-cell treatment for spinal-cord injuries after the FDA lifted a nearly yearlong hold on the trial.
Read this article: Geron to Resume Stem-Cell Study
Name (required)
E-mail (required, not be published!)
URI